Ante la inminencia de los plazos fijados por los organismos gubernamentales, todas las empresas farmacéuticas deben evaluar y controlar el contenido de nitrosaminas en sus medicamentos. Las soluciones suelen ser multicapa y pueden incluir eliminadores de nitritos sencillos y seguros en la formulación final del fármaco. En esta charla electrónica de la AAPS los expertos de dsm-firmenich debaten las consideraciones clave para la mitigación de las nitrosaminas en los productos farmacéuticos mediante el uso de secuestrantes de nitritos.
Objetivos de aprendizaje:
Esta sesión dura 30 minutos.
Ascorbic acid, and other nitrite scavengers, have been shown to act as functional excipients in drug products that can reduce nitrosamine formation by blocking nitrosation reactions.
Discover the latest insights on nitrosamine risk mitigation presented by dsm-firmenich during an eChalk Talk hosted by the American Association of Pharmaceutical Scientists (AAPS).
Discover how dsm-firmenich is turning insights into innovation this World Patient Safety Day, from nitrosamine risk mitigation to cannabinoid-based therapeutics.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.